series-c-plus
Stage
2017
Founded
1
Investors
About
Vect-Horus is a biotechnology company that develops molecular vectors using its proprietary VECTrans® technology to facilitate the targeted delivery of therapeutic and imaging agents to organs, including the brain and tumors. They operate with a mixed business model, developing an internal pipeline of drug candidates and partnering with pharmaceutical companies for research collaborations and licensing.
Explore Vect-Horus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.